Search Browse Earnings

OptiNose, Inc. — SlamSEC

OptiNose, Inc.

Pharmaceutical Preparations·YARDLEY, PA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$71.0M

-6.9% YoY

FY 2024

Adj. EBITDA

-$22.3M

-31.5% margin

FY 2024

Net Income

-$35.5M

-50.0% margin

FY 2024

EPS (Diluted)

-$4.75

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$73.7M

FY 2024

Total Debt

$256.6M

FY 2022

Net Debt

$183.0M

FY 2022

Enterprise Value

—

Debt / EBITDA

-8.2x

FY 2024

EV / EBITDA

—

Employees

—

CFO

Kohler Terry